Diagnostic role of transient elastography in patients with autoimmune liver diseases: A systematic review and meta-analysis

World J Gastroenterol. 2023 Oct 21;29(39):5503-5525. doi: 10.3748/wjg.v29.i39.5503.

Abstract

Background: Noninvasive methods have been developed to detect fibrosis in many liver diseases due to the limits of liver biopsy. However, previous studies have focused primarily on chronic viral hepatitis and nonalcoholic fatty liver disease. The diagnostic value of transient elastography for autoimmune liver diseases (AILDs) is worth studying.

Aim: To compare the diagnostic accuracy of imaging techniques with serum biomarkers of fibrosis in AILD.

Methods: The PubMed, Cochrane Library and EMBASE databases were searched. Studies evaluating the efficacy of noninvasive methods in the diagnosis of AILDs [autoimmune hepatitis (AIH), primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC)] were included. The summary area under the receiver operating characteristic curve (AUROC), diagnostic odds ratio, sensitivity and specificity were used to assess the accuracy of these noninvasive methods for staging fibrosis.

Results: A total of 60 articles were included in this study, and the number of patients with AIH, PBC and PSC was 1594, 3126 and 501, respectively. The summary AUROC of transient elastography in the diagnosis of significant fibrosis, advanced fibrosis and cirrhosis in patients with AIH were 0.84, 0.88 and 0.90, respectively, while those in patients with PBC were 0.93, 0.93 and 0.91, respectively. The AUROC of cirrhosis for patients with PSC was 0.95. However, other noninvasive indices (aspartate aminotransferase to platelet ratio index, aspartate aminotransferase/alanine aminotransferase ratio, fibrosis-4 index) had corresponding AUROCs less than 0.80.

Conclusion: Transient elastography exerts better diagnostic accuracy in AILD patients, especially in PBC patients. The appropriate cutoff values for staging advanced fibrosis and cirrhosis ranged from 9.6 to 10.7 and 14.4 to 16.9 KPa for PBC patients.

Keywords: Autoimmune liver disease; Liver fibrosis; Liver stiffness; Noninvasive diagnosis; Serum parameter; Transient elastography.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Aspartate Aminotransferases
  • Elasticity Imaging Techniques* / methods
  • Fibrosis
  • Hepatitis, Autoimmune* / complications
  • Hepatitis, Autoimmune* / diagnostic imaging
  • Humans
  • Liver / diagnostic imaging
  • Liver / pathology
  • Liver Cirrhosis / diagnosis
  • Liver Cirrhosis / diagnostic imaging
  • Non-alcoholic Fatty Liver Disease* / pathology
  • ROC Curve

Substances

  • Aspartate Aminotransferases